Artia Global Partners Lp

Top Portfolio
Top Buys
Top Sells
New Buys
Exits
Verona Pharma plc
VRNA
$2.1M1.29130,7900%+$00.52
Ocular Therapeutix, Inc.
OCUL
$6.59M0.47724,685+64.7%+$2.59M1.63
RAPT Therapeutics, Inc.
RAPT
$1.23M0.4137,308+599.2%+$1.06M0.31
Viking Therapeutics, Inc.
VKTX
$35.55M0.39433,580+13.04%+$4.1M8.79
Disc Medicine, Inc.
IRON
$5.42M0.3587,040New+$5.42M1.34
Mereo BioPharma Group plc
MREO
$1.39M0.3421,359New+$1.39M0.34
Protagonist Therapeutics, Inc.
PTGX
$3.6M0.21124,440+10.77%+$350,052.980.89
Intra-Cellular Therapies, Inc.
ITCI
$14.54M0.2210,096+405.04%+$11.66M3.6
Axsome Therapeutics, Inc.
AXSM
$7.01M0.1987,8480%+$01.73
Pliant Therapeutics, Inc.
PLRX
$1.49M0.17100,0000%+$00.37
Annexon, Inc.
ANNX
$1.06M0.16147,485New+$1.06M0.26
Dyne Therapeutics, Inc.
DYN
$3.39M0.12119,488New+$3.39M0.84
Soleno Therapeutics, Inc.
SLNO
$1.75M0.1240,924New+$1.75M0.43
Silence Therapeutics plc
SLN
$1.13M0.1152,476New+$1.13M0.28
Crinetics Pharmaceuticals, Inc.
CRNX
$4.01M0.1185,765New+$4.01M0.99
Apogee Therapeutics, Inc.
APGE
$4.09M0.1161,590+493.3%+$3.4M1.01
MacroGenics, Inc.
MGNX
$942,183.000.164,007New+$942,183.000.23
EyePoint Pharmaceuticals, Inc.
EYPT
$1.06M0.151,500+3%+$31,005.000.26
Biomea Fusion, Inc.
BMEA
$530,007.000.135,452+39.29%+$149,499.890.13
Janux Therapeutics, Inc.
JANX
$1.81M0.0947,949New+$1.81M0.45
Larimar Therapeutics, Inc.
LRMR
$441,662.000.0958,190New+$441,662.000.11
Poseida Therapeutics, Inc.
PSTX
$274,346.000.0986,002New+$274,346.000.07
Gritstone bio, Inc.
GRTS
$244,587.000.0995,1700%+$00.06
Merus N.V.
MRUS
$2.26M0.0950,171New+$2.26M0.56
Insmed Incorporated
INSM
$3.21M0.08118,236+57.78%+$1.17M0.79
Cytokinetics, Incorporated
CYTK
$6.28M0.0889,525+178.78%+$4.03M1.55
SpringWorks Therapeutics, Inc.
SWTX
$2.65M0.0753,930New+$2.65M0.66
Vaxcyte, Inc.
PCVX
$5.21M0.0776,255+97.78%+$2.58M1.29
IDEAYA Biosciences, Inc.
IDYA
$2.3M0.0752,492New+$2.3M0.57
Arvinas, Inc.
ARVN
$1.65M0.0640,000New+$1.65M0.41
argenx SE
ARGX
$13.48M0.0634,2380%+$03.33
Xenon Pharmaceuticals Inc.
XENE
$1.72M0.0540,000New+$1.72M0.43
Kura Oncology, Inc.
KURA
$842,066.000.0539,478New+$842,066.000.21
Neurocrine Biosciences, Inc.
NBIX
$6.21M0.0545,0000%+$01.54
Vera Therapeutics, Inc.
VERA
$1.05M0.0424,298New+$1.05M0.26
Ascendis Pharma A/S
ASND
$2.4M0.0315,894New+$2.4M0.59
Novo Nordisk A/S
NVO
$88.82M0.02691,743-4.13%-$3.82M21.97
Merck & Co., Inc.
MRK
$50.04M0.02379,200+15.19%+$6.6M12.37
Immunovant, Inc.
IMVT
$691,337.000.0221,3970%+$00.17
Charles River Laboratories International, Inc.
CRL
$1.87M0.016,9050%+$00.46
AstraZeneca PLC
AZN
$12.92M0.01190,7520%+$03.2
Vertex Pharmaceuticals Incorporated
VRTX
$12.08M0.0128,900New+$12.08M2.99
Eli Lilly and Company
LLY
$72.03M0.0192,5930%+$017.82
Madrigal Pharmaceuticals, Inc.
MDGL
$415,781.000.011,557New+$415,781.000.1
AbbVie Inc.
ABBV
$16.54M0.0190,8210%+$04.09